GRFS logo

Grifols SA (GRFS)

Profile

Full Name

Grifols, S.A.

Ticker Symbol

GRFS

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

Spain

IPO

June 2, 2011

Indexes

Not included

Website

http://www.grifols.com

Employees

23833

Key Details

Price

$7.00(+3.55%)

Market cap

$4.76B(Mid cap)

Last Dividend

$0.46

TTM Dividend yield

-

Annual revenue

$7.81B(+9.39% YoY)

Annual EPS

$0.25(+155.54% YoY)

PE ratio

32.85

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.00
GRFS price is $7.00

30-Day Relative Volume

0.70
GRFS 30-day relative volume is 0.70

Price Performance

Price Most recent change

+3.55%
GRFS price was up +3.55% on Apr 14, 2025

Price YTD change

-5.91%
GRFS price is down -5.91% since January 1st

Price 1-year change

+6.71%
GRFS price is up +6.71% year-on-year

Price 3-year change

-34.94%
GRFS price is down -34.94% over the past 3 years

Price Range

Price All-time high

$25.73
GRFS price is currently -72.79% below its historical high of $25.73

Price 3-year low

$5.30
GRFS price is currently +32.08% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.76B
GRFS market capitalization is $4.76 billion

Market cap 3-year change

-34.77%
GRFS market capitalization is down -34.77% over the past 3 years

Market cap All-time high

$22.04B
GRFS market capitalization is currently -78.39% below its historical high of $22.04 billion

Market cap sector rank

88.9%
GRFS market capitalization is higher than 88.9% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.19%
GRFS shares outstanding is up +0.19% year-on-year

Shares Outstanding 3-Year Change

+0.28%
GRFS shares outstanding is up +0.28% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.85
GRFS beta is 0.85

200-day SMA

$7.95
GRFS price is currently -11.90% below its 200-day simple moving average

50-day SMA

$7.48
GRFS price is currently -6.46% below its 50-day simple moving average

RSI

45.98
GRFS 14-day relative strength index is 45.98

Volume

0.70
GRFS 30-day relative volume is 0.70

ATR

$0.41
GRFS average true range is $0.41

10-day Historical Volatility

82.01%
GRFS 10-day historical volatility is 82.01%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.46
GRFS last dividend was $0.46 per share, with an ex-dividend date of June 3, 2021

Next Dividend

-
GRFS next dividend has not yet been announced

Dividend per share

Dividend per share

-
GRFS annual dividend per share value is unknown

Dividend per share Sector Rank

-
GRFS annual dividend per share is unknown

Dividend per share 1-Year Change

-
GRFS annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
GRFS annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
GRFS annual dividend yield value is unknown

Dividend yield Sector Rank

-
GRFS annual dividend yield is unknown

Other

Payout ratio

0.61%
GRFS annual payout ratio is 0.61%

Dividends paid

$1.04M
GRFS annual dividends paid is $1.04 million

Free cash flow

$574.51M
GRFS annual free cash flow is $574.51 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.81B
GRFS annual revenue is $7.81 billion

Revenue Analysts estimate

$7.72B
GRFS annual revenue is currently +1.17% higher than the consensus analysts' forecast

Revenue 1-year change

+9.39%
GRFS annual revenue is up +9.39% year-on-year

Revenue Sector rank

93.28%
GRFS annual revenue is higher than 93.28% of companies in Healthcare sector

EPS

EPS

$0.25
GRFS annual earnings per share is $0.25

EPS Analysts estimate

$0.98
GRFS annual earnings per share is currently -74.48% lower than the consensus analysts' forecast

EPS 1-year change

+155.54%
GRFS annual earnings per share is up +155.54% year-on-year

EPS Sector rank

85.14%
GRFS annual earnings per share is higher than 85.14% of companies in Healthcare sector

Profit

Gross profit

$3.02B
GRFS annual gross profit is $3.02 billion

Gross margin

38.75%
GRFS annual gross profit margin is 38.75%

Operating profit

$1.25B
GRFS annual operating income is $1.25 billion

Operating margin

16.02%
GRFS annual operating profit margin is 16.02%

Net income

$169.84M
GRFS annual net profit is $169.84 million

Net margin

2.18%
GRFS annual net profit margin is 2.18%

Expenses

Total expenses

$6.56B
GRFS annual total expenses is $6.56 billion

Operating expenses

$1.77B
GRFS annual total operating expenses is $1.77 billion

Cost of goods sold

$4.78B
GRFS annual cost of goods sold is $4.78 billion

Selling, general & administrative expenses

$1.36B
GRFS annual SGA is $1.36 billion

Depreciation and amortization

$473.96M
GRFS annual depreciation & amortization is $473.96 million

Interest expense

$652.19M
GRFS annual interest expense is $652.19 million

Income tax

$250.23M
GRFS annual income tax is $250.23 million

EBIT & EBITDA

EBIT

$1.13B
GRFS annual earnings before interest & taxes is $1.13 billion

EBITDA

$1.61B
GRFS annual EBITDA is $1.61 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$22.27B
GRFS annual total assets is $22.27 billion

Non current assets

$16.31B
GRFS annual long term assets is $16.31 billion

Current assets

$5.96B
GRFS annual total current assets is $5.96 billion

Cash and cash equivalents

$1.02B
GRFS annual cash & cash equivalents is $1.02 billion

Accounts receivable

$734.07M
GRFS annual accounts receivable is $734.07 million

Inventory

$3.70B
GRFS annual inventory is $3.70 billion

Liabilities

Total liabilities

$13.32B
GRFS annual total liabilities is $13.32 billion

Long term liabilities

$11.07B
GRFS annual total long term liabilities is $11.07 billion

Current liabilities

$2.24B
GRFS annual total current liabilities is $2.24 billion

Accounts payable

$886.88M
GRFS annual accounts payable is $886.88 million

Debt

Total debt

$10.53B
GRFS annual total debt is $10.53 billion

Total debt 1-year change

-5.81%
GRFS annual total debt is down -5.81% year-on-year

Long term debt

$9.88B
GRFS annual long term debt is $9.88 billion

Short term debt

$658.42M
GRFS annual short term debt is $658.42 million

Equity & Capital

Shareholders equity

$6.12B
GRFS annual stockholders equity is $6.12 billion

Book value

$6.12B
GRFS annual book value is $6.12 billion

Retained earnings

$163.29M
GRFS annual retained earnings is $163.29 million

Working capital

$3.72B
GRFS annual working capital is $3.72 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$976.46M
GRFS annual cash flow from operations is $976.46 million

Cash from operations 1-year change

+333.04%
GRFS annual cash flow from operations is up +333.04% year-on-year

Cash from investing

$959.68M
GRFS annual cash flow from investing activities is $959.68 million

Cash from investing 1-year change

+322.93%
GRFS annual cash flow from investing activities is up +322.93% year-on-year

Cash from financing

-$1.47B
GRFS annual cash flow from financing activities is -$1.47 billion

Cash from financing 1-year change

-830.14%
GRFS annual cash flow from financing activities is down -830.14% year-on-year

CAPEX

CAPEX

$401.95M
GRFS annual capital expenditures is $401.95 million

CAPEX 1-year change

+25.68%
GRFS annual capital expenditures is up +25.68% year-on-year

Free Cash Flow

Free cash flow

$574.51M
GRFS annual free cash flow is $574.51 million

Free cash flow 1-year change

+709.01%
GRFS annual free cash flow is up +709.01% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

38.75%
GRFS annual gross profit margin is 38.75%

Operating margin

16.02%
GRFS annual operating profit margin is 16.02%

Net margin

2.18%
GRFS annual net profit margin is 2.18%

ROA & ROE

ROA

0.74%
GRFS annual return on assets is 0.74%

ROE

1.91%
GRFS annual return on equity is 1.91%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

32.85
GRFS price to earnings ratio is 32.85

PE ratio Sector rank

64.71%
GRFS price to earnings ratio is higher than 64.71% of companies in Healthcare sector

PB Ratio

PB ratio

0.78
GRFS price to book ratio is 0.78

PB ratio Sector rank

38.85%
GRFS price to book ratio is higher than 38.85% of companies in Healthcare sector

PS Ratio

PS ratio

0.79
GRFS price to sales ratio is 0.79

PS ratio Sector rank

23.33%
GRFS price to sales ratio is higher than 23.33% of companies in Healthcare sector

Enterprise value

Enterprise value

$14.28B
GRFS enterprise value is $14.28 billion

Enterprise value Sector rank

93.8%
GRFS enterprise value is higher than 93.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

11.13
GRFS EV/EBITDA is 11.13

EV/EBITDA Sector rank

83.65%
GRFS EV/EBITDA is higher than 83.65% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.66
GRFS annual current ratio is 2.66

Quick ratio

1.01
GRFS annual quick ratio is 1.01

Leverage

Debt to equity

1.53
GRFS annual debt to equity ratio is 1.53

Interest coverage ratio

1.74
GRFS annual interest coverage ratio is 1.74

Risk & Stability

Piotroski F-Score

-
GRFS piotroski f-score value is unknown

Altman Z-Score

0.94
GRFS altman z-score is 0.94

Analyst ratings

Recent major analysts updates

Mar 12, 24 Deutsche Bank
Sell
Dec 5, 23 JP Morgan
Neutral
Nov 5, 21 Deutsche Bank
Hold
Mar 23, 21 Credit Suisse
Outperform
Mar 11, 21 HSBC
Buy
Oct 28, 19 Santander
Buy
Jun 27, 19 JP Morgan
Overweight
Feb 8, 19 Berenberg
Hold
Jan 2, 19 Morgan Stanley
Underweight
Oct 1, 18 Morgan Stanley
Underweight

Institutional Ownership

Similar stocks

CYTK logo
Cytokinetics Incorporated (CYTK)
KRYS logo
Krystal Biotech (KRYS)
VRNA logo
Verona Pharma (VRNA)
IONS logo
Ionis Pharmaceuticals (IONS)
ADMA logo
ADMA Biologics (ADMA)
NUVL logo
Nuvalent (NUVL)
ALKS logo
Alkermes (ALKS)
AXSM logo
Axsome Therapeutics (AXSM)
INSP logo
Inspire Medical Systems (INSP)
  • What is the ticker symbol for Grifols SA?
  • Does Grifols SA pay dividends?
  • What sector is Grifols SA in?
  • What industry is Grifols SA in?
  • What country is Grifols SA based in?
  • When did Grifols SA go public?
  • Is Grifols SA in the S&P 500?
  • Is Grifols SA in the NASDAQ 100?
  • Is Grifols SA in the Dow Jones?
  • When was Grifols SA's last earnings report?
  • When does Grifols SA report earnings?

What is the ticker symbol for Grifols SA?

The ticker symbol for Grifols SA is NASDAQ:GRFS

Does Grifols SA pay dividends?

No, Grifols SA does not pay dividends

What sector is Grifols SA in?

Grifols SA is in the Healthcare sector

What industry is Grifols SA in?

Grifols SA is in the Drug Manufacturers - General industry

What country is Grifols SA based in?

Grifols SA is headquartered in Spain

When did Grifols SA go public?

Grifols SA's initial public offering (IPO) was on June 2, 2011

Is Grifols SA in the S&P 500?

No, Grifols SA is not included in the S&P 500 index

Is Grifols SA in the NASDAQ 100?

No, Grifols SA is not included in the NASDAQ 100 index

Is Grifols SA in the Dow Jones?

No, Grifols SA is not included in the Dow Jones index

When was Grifols SA's last earnings report?

Grifols SA's most recent earnings report was on Feb 26, 2025

When does Grifols SA report earnings?

The next expected earnings date for Grifols SA is May 14, 2025
On this page